# Corza Health acquires TachoSil surgical patch from Takeda for $422.4M

Takeda completed the sale of its TachoSil Fibrin Sealant Patch to Corza Health for €350 million ($422.4 million) in cash. The deal includes assets and licenses for development and commercialization, while Takeda retains the manufacturing facility in Linz, Austria.

- Type: Acquisition
- Announced: 2021-02-02
- Where: Linz, Austria, Austria
- Value: $422.4M (350.0M EUR)
- Status: completed
- Products: TachoSil Fibrin Sealant Patch, surgical patch
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Takeda](https://endata.com/companies/52956.md) (target)
- [Corza Health](https://endata.com/companies/52988.md) (acquirer)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/takeda-tachosil-corza-health/), 2021-02-02: "Takeda remains focused on executing its long-term growth strategy to optimise our business mix around our key business areas, and simplifying our operations to better serve patients by delivering innovative treatments in these areas."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.